# Efficacy and Safety of FF-31501 in Meniscus Tear Patients

> **NCT05777967** · PHASE3 · UNKNOWN · sponsor: **FUJIFILM Toyama Chemical Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Meniscus Injury

## Interventions

- **BIOLOGICAL:** human autologous synovial stem cells

## Key facts

- **NCT ID:** NCT05777967
- **Lead sponsor:** FUJIFILM Toyama Chemical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05777967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05777967, "Efficacy and Safety of FF-31501 in Meniscus Tear Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05777967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*